ATP6V1B2 Gene

HGNC Family	ATPases
Name	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2
Description	This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. The protein encoded by this gene is one of two V1 domain B subunit isoforms and is the only B isoform highly expressed in osteoclasts. [provided by RefSeq, Jul 2008]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ATP6V1B2 encodes the B2 subunit of the vacuolar‐type H⁺‑ATPase (v‑ATPase), a multisubunit proton pump essential for acidification of intracellular compartments and proper lysosomal function. A growing body of evidence demonstrates that ATP6V1B2 plays multiple roles in cellular homeostasis and diverse disease processes. In the central nervous system, genetic variation in ATP6V1B2 has been linked to major depressive disorder and cognitive deficits, with studies reporting that risk‐associated alleles correlate with impaired hippocampal‐dependent function and altered synaptic vesicle acidification (for instance"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Moreover, differential expression of ATP6V1B2 in the brain has been shown to vary among ApoE isoforms, suggesting its involvement in synaptic integrity and possibly contributing to Alzheimer’s disease pathology when expression is low."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the kidney, ATP6V1B2‐containing v‑ATPase complexes contribute to acid–base homeostasis. Notably, in mice lacking the B1 subunit, a relocalization of B2‐containing complexes to the apical membrane of intercalated cells permits a residual proton secretion necessary for baseline pH regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Similarly, in ameloblasts, ATP6V1B2 appears to be involved in intracellular acidification rather than in direct extracellular proton pumping, highlighting cell type–specific roles of the v‑ATPase."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In the context of neoplastic and developmental disorders, somatic mutations in ATP6V1B2 have been identified in follicular lymphoma, where they co‐occur with alterations in regulators of the amino acid sensing pathway to promote autophagic flux and sustain mTORC1 signaling under nutrient stress"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Germline mutations in ATP6V1B2 underlie syndromic forms of deafness combined with nail and dental anomalies. These include Zimmermann–Laband syndrome, deafness–onychodystrophy (DDOD), and DOORS syndrome, with affected individuals displaying variable neurodevelopmental features and, in some cases, epilepsy"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "10"}]}, {"type": "t", "text": ", and."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, emerging evidence links ATP6V1B2 to cellular metabolic regulation. In adipocytes, ATP6V1B2 has been identified as a target of SIRT1‐mediated deacetylation, suggesting that post‐translational modification of this v‑ATPase subunit may modulate energy metabolism and intracellular pH in a manner relevant to metabolic homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings underscore the multifaceted roles of ATP6V1B2 in regulating lysosomal acidification, autophagy, and cellular signaling across diverse tissues. Disruption of ATP6V1B2 function—either through genetic variation or mutation—can compromise essential processes such as neurotransmission, intracellular pH homeostasis, and mTORC1-mediated metabolic sensing, thereby contributing to neuropsychiatric, metabolic, and neoplastic diseases."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "8"}, {"type": "fg_f", "ref": "6"}, {"type": "fg_f", "ref": "4"}, {"type": "fg_f", "ref": "9"}, {"type": "fg_f", "ref": "3"}, {"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "12"}, {"type": "fg_f", "ref": "5"}, {"type": "fg_f", "ref": "10"}, {"type": "fg_f", "ref": "2"}, {"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S I Shyn, J Shi, J B Kraft, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mp.2009.125"}], "href": "https://doi.org/10.1038/mp.2009.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20038947"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20038947"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "X Gonda, N Eszlari, I M Anderson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of ATP6V1B2 rs1106634 with lifetime risk of depression and hippocampal neurocognitive deficits: possible novel mechanisms in the etiopathology of depression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2016.221"}], "href": "https://doi.org/10.1038/tp.2016.221"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27824360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27824360"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sarah K Woody, Helen Zhou, Shaher Ibrahimi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Alzheimers Dis (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/JAD-160307"}], "href": "https://doi.org/10.3233/JAD-160307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27340853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27340853"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Teodor G Paunescu, Leileata M Russo, Nicolas Da Silva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Compensatory membrane expression of the V-ATPase B2 subunit isoform in renal medullary intercalated cells of B1-deficient mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00160.2007"}], "href": "https://doi.org/10.1152/ajprenal.00160.2007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17898041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17898041"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wenjun Li, Piero G Antuono, Chunming Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuroimage (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuroimage.2011.12.077"}], "href": "https://doi.org/10.1016/j.neuroimage.2011.12.077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22245641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22245641"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jessica Okosun, Rachel L Wolfson, Jun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3473"}], "href": "https://doi.org/10.1038/ng.3473"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26691987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26691987"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fangyang Wang, Damián Gatica, Zhang Xiao Ying, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI98288"}], "href": "https://doi.org/10.1172/JCI98288"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30720463"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30720463"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Fanny Kortüm, Viviana Caputo, Christiane K Bauer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.3282"}], "href": "https://doi.org/10.1038/ng.3282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25915598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25915598"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Weihao Zhao, Xue Gao, Shiwei Qiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A subunit of V-ATPases, ATP6V1B2, underlies the pathology of intellectual disability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2019.06.035"}], "href": "https://doi.org/10.1016/j.ebiom.2019.06.035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31257146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31257146"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Marie Shaw, Anna Winczewska-Wiktor, Magdalena Badura-Stronka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EXOME REPORT: Novel mutation in ATP6V1B2 segregating with autosomal dominant epilepsy, intellectual disability and mild gingival and nail abnormalities."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Med Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejmg.2019.103799"}], "href": "https://doi.org/10.1016/j.ejmg.2019.103799"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31655144"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31655144"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Eliane Beauregard-Lacroix, Guillermo Pacheco-Cuellar, Norbert F Ajeawung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DOORS syndrome and a recurrent truncating ATP6V1B2 variant."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41436-020-00950-9"}], "href": "https://doi.org/10.1038/s41436-020-00950-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32873933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32873933"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sun-Yee Kim, Qiongyi Zhang, Reinhard Brunmeir, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SIRT1 Interacts with and Deacetylates ATP6V1B2 in Mature Adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0133448"}], "href": "https://doi.org/10.1371/journal.pone.0133448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26177453"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26177453"}]}]}]}
Synonyms	HO57, ATP6B2, ZLS2, ATP6B1B2, DOOD
Proteins	VATB2_HUMAN
NCBI Gene ID	526
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

ATP6V1B2 has 8,123 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 122 datasets.

Click the + buttons to view associations for ATP6V1B2 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

ATP6V1B2 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Achilles Cell Line Gene Essentiality Profiles	cell lines with fitness changed by ATP6V1B2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of ATP6V1B2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of ATP6V1B2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of ATP6V1B2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of ATP6V1B2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of ATP6V1B2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of ATP6V1B2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of ATP6V1B2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of ATP6V1B2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of ATP6V1B2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of ATP6V1B2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CCLE Cell Line Proteomics	Cell lines associated with ATP6V1B2 protein from the CCLE Cell Line Proteomics dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with ATP6V1B2 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of ATP6V1B2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of ATP6V1B2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of ATP6V1B2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of ATP6V1B2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing ATP6V1B2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing ATP6V1B2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores	cellular components containing ATP6V1B2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
	COMPARTMENTS Experimental Protein Localization Evidence Scores 2025	cellular components containing ATP6V1B2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with ATP6V1B2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with ATP6V1B2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of ATP6V1B2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with ATP6V1B2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with ATP6V1B2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with ATP6V1B2 gene/protein from the curated CTD Gene-Disease Associations dataset.
	dbGAP Gene-Trait Associations	traits associated with ATP6V1B2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
	DeepCoverMOA Drug Mechanisms of Action	small molecule perturbations with high or low expression of ATP6V1B2 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores	diseases associated with ATP6V1B2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with ATP6V1B2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with ATP6V1B2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with ATP6V1B2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with ATP6V1B2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	DrugBank Drug Targets	interacting drugs for ATP6V1B2 protein from the curated DrugBank Drug Targets dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at ATP6V1B2 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of ATP6V1B2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of ATP6V1B2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing ATP6V1B2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GAD Gene-Disease Associations	diseases associated with ATP6V1B2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.